General Information of Drug (ID: DMXMJL8)

Drug Name
PSMA ADC therapeutic
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Phase 2 [1]
Cross-matching ID
TTD ID
D0A7LL

References

1 J Clin Oncol 32, 2014 (suppl 4; abstr 83).